Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAdjuvants, ImmunologicCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideTreatment OutcomeDoxorubicinBreast NeoplasmsDisease-Free SurvivalNeoadjuvant TherapyNeoplasm StagingRadiotherapy, AdjuvantSurvival AnalysisPrognosisEtoposideSurvival RateFreund's AdjuvantDrug Administration ScheduleMethotrexateLung NeoplasmsNeoplasm Recurrence, LocalCarboplatinPaclitaxelVinblastineTaxoidsInduction ChemotherapyAntimetabolites, AntineoplasticDrug Resistance, NeoplasmIfosfamideAdjuvants, PharmaceuticOrganoplatinum CompoundsDeoxycytidineNeoplasmsBleomycinFollow-Up StudiesAnthracyclinesAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungNeoplasm MetastasisAdenocarcinomaChemotherapy, Cancer, Regional PerfusionSalvage TherapyCytarabineTime FactorsOvarian NeoplasmsTesticular NeoplasmsColorectal NeoplasmsNeutropeniaClinical Trials as TopicVomitingRadiotherapyAntineoplastic Agents, PhytogenicTransplantation, AutologousNauseaLymphatic MetastasisKaplan-Meier EstimateLymphoma, Non-HodgkinProspective StudiesHodgkin DiseaseDacarbazineAntibiotics, AntineoplasticLomustineBrain NeoplasmsBone NeoplasmsTumor Markers, BiologicalNeoplasms, Germ Cell and EmbryonalCarmustineGranulocyte Colony-Stimulating FactorTamoxifenTegafurCamptothecinMitomycinRandomized Controlled Trials as TopicOsteosarcomaPlatinum CompoundsStomach NeoplasmsRecurrenceAntibodies, Monoclonal, HumanizedLiver NeoplasmsInfusions, Intra-ArterialDose-Response Relationship, DrugMelphalanLeukopeniaThiotepaInfusions, IntravenousRadiotherapy DosageAntiemeticsDrug TherapyPeritoneal NeoplasmsMitoxantronePalliative CareHematopoietic Stem Cell TransplantationCell Line, TumorCarcinomaAntineoplastic Agents, HormonalGerminomaCarcinoma, Squamous CellDisease Progression